Stay updated with breaking news from Arthurf Ryan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AJOVista LLC purchased a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 163 shares of the biopharmaceutical company’s stock, valued at approximately $143,000. Other institutional investors also recently made changes to their positions in the company. […]
Jackson Creek Investment Advisors LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 673 shares of the biopharmaceutical company’s stock after selling 23 shares during the period. Jackson […]
Navis Wealth Advisors LLC reduced its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 11.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,120 shares of the biopharmaceutical company’s stock after selling 150 shares during […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective hoisted by TD Cowen from $1,020.00 to $1,030.00 in a report published on Wednesday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other analysts also recently commented on the stock. Truist Financial restated a buy rating […]
Tokio Marine Asset Management Co. Ltd. raised its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,420 shares of the biopharmaceutical company’s stock after buying an additional 81 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Regeneron Pharmaceuticals were […]